Skip to main content
. 2019 Sep;25(9):10.18553/jmcp.2019.25.9.1001. doi: 10.18553/jmcp.2019.25.9.1001

TABLE 4.

Logistic Regression Comparing Odds of Adding or Switching in Second-Line Therapy

Adding Alternative Medicationsa Switching to Alternative Medicationsa
Odds Ratio (95% CI) Wald X2 P Valueb Odds Ratio (95% CI) Wald X2 P Valueb
PGA type
  Latanoprost (ref.)
  Travoprost 1.43 (1.10-1.86) 5.50 0.019 0.96 (0.78-1.19) 0.81 0.368
  Bimatoprost 1.21 (0.92-1.58) 0.01 0.923 0.79 (0.63-0.97) 5.33 0.021
Age (continuous) 1.01 (0.99-1.02) 0.86 0.353 1.00 (0.99-1.01) 0.27 0.601
Gender
  Male (ref.)
  Female 0.99 (0.80-1.23) 0.01 0.939 1.12 (0.94-1.34) 1.59 0.208
Race/ethnicity
  White (ref.)
  Nonwhite 1.23 (0.97-1.56) 2.97 0.085 0.81 (0.66-0.99) 4.23 0.040
Geographic region
  Non-South (ref.)
  South 1.16 (0.91-1.48) 1.44 0.230 1.29 (1.06-1.57) 6.41 0.011
CCI score (continuous) 1.00 (0.99-1.00) 0.94 0.331 1.00 (0.99-1.00) 0.01 0.909
Type of glaucoma
  Non-OAG (ref.)
  OAG 1.56 (1.20-2.04) 10.91 0.001 0.91 (0.75-1.11) 0.87 0.350
Ocular disorder
  No (ref.)
  Yes 1.05 (0.81-1.35) 0.13 0.721 1.23 (0.99-1.53) 3.48 0.062
Hypertension
  No (ref.)
  Yes 0.91 (0.70-1.18) 0.52 0.471 0.97 (0.78-1.20) 0.10 0.751
Diabetes
  No (ref.)
  Yes 0.87 (0.68-1.12) 1.15 0.283 0.96 (0.78-1.18) 0.15 0.697
Pre-index number of outpatient visits (continuous) 1.00 (0.99-1.01) 0.82 0.366 1.00 (0.99-1.01) 0.42 0.518
Pre-index inpatient visits
  No (ref.)
  Yes 1.06 (0.77-1.47) 0.14 0.705 1.06 (0.81-1.38) 0.19 0.662

aConditional logistic regression model was used for adding alternative medications (Yes/No) and switching to alternative medications (Yes/No).

bSignificant at P < 0.05 (in bold).

CCI = Charlson Comorbidity Index; CI = confidence interval; OAG = open-angle glaucoma; PGA = prostaglandin analog; ref. = reference; X2 = chi-square.